Spiden
Spiden provides and develops products that enable real-time and continuous monitoring of blood biomarkers.
Spiden is a business in artificial intelligence (ai), biotechnology based in Europe, Middle East, and Africa (EMEA), founded in 2017.
Its activity falls under artificial intelligence (ai), biotechnology; the profile below is assembled from public directory data.
The business is associated with Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Convertible_Note.
Its team size is recorded as c_00011_00050 employees.
Total disclosed funding stands at about $40.3M.
| Sector | Artificial Intelligence (AI), Biotechnology |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2017 |
| Employees | c_00011_00050 |
| Stage | convertible_note |
| Total funding | $40,250,000 |
Website: www.spiden.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account